Tatsuhiko Urakami 研究室

主宰者：Tatsuhiko Urakami

日本大学

AI 要約（直近 5 年の研究成果）

要約はまだ生成されていません。

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

外部リンク

研究成果（30 件）

[2026] Pharmacokinetics, Pharmacodynamics, and Safety of Single‐Dose Luseogliflozin (TS‐071) in Japanese Children and Adolescents With Type 2 Diabetes: A Multicenter, Open‐Label, Parallel‐Group Phase 1 Study
DOI: https://doi.org/10.1002/cpdd.70065
[2025] 950-P: A Multicenter Retrospective Observational Study of the Safety and the Effectiveness of the MEDISAFE WITH Patch Insulin Pump—MW-Safety Study
DOI: https://doi.org/10.2337/db25-950-p
[2024] Acetonemic vomiting: a potential complication of treatment with glucagon-like peptide-1 receptor agonists especially in lean type 2 diabetes patients
DOI: https://doi.org/10.1007/s13340-024-00758-x
[2024] Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes
DOI: https://doi.org/10.1111/jdi.14303
[2024] Questionnaire survey on severe hypoglycemia in pediatric patients with diabetes-English version
DOI: https://doi.org/10.1007/s13340-024-00742-5
[2024] Glycemic metrics in Japanese <scp>isCGM</scp> users – Analysis by diabetes type and therapy
DOI: https://doi.org/10.1111/jdi.14233
[2024] A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (<scp>EMPIRE</scp>‐02)
DOI: https://doi.org/10.1111/jdi.14226
[2024] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
DOI: https://doi.org/10.1007/s13300-023-01526-x
[2024] Clinical characteristics in children with maturity-onset diabetes of the young detected by urine glucose screening at schools in the Tokyo Metropolitan Area
DOI: https://doi.org/10.1297/cpe.2024-0009
[2024] Diabetes mellitus with severe insulin resistance in a young male patient with a heterozygous pathogenic <i>IRS1</i> frameshift variant
DOI: https://doi.org/10.1297/cpe.2023-0081

続きを表示（残り 20 件）

[2023] Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes
DOI: https://doi.org/10.2169/internalmedicine.9632-22
[2023] Difference in the early clinical course between children with type 1 diabetes having a single antibody and those having multiple antibodies against pancreatic β-cells
DOI: https://doi.org/10.1507/endocrj.ej22-0432
[2023] Pathophysiological significance in abdominal fat distribution in non-obese children with type 2 diabetes
DOI: https://doi.org/10.1507/endocrj.ej22-0449
[2023] Nighttime hypoglycemia in Japanese children with type 1 diabetes mellitus treated with multiple daily injection insulin therapy
DOI: https://doi.org/10.1507/endocrj.ej22-0379
[2022] Association of Plasma Cortisol Levels with Gestational Age and Anthropometric Values at Birth in Preterm Infants
DOI: https://doi.org/10.3390/ijerph191811448
[2022] Comparison of the clinical effects of intermittently scanned and real‐time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study
DOI: https://doi.org/10.1111/jdi.13830
[2022] Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region
DOI: https://doi.org/10.5409/wjcp.v11.i2.173
[2022] Significance of the CGM metric of time in range in children and adolescents with type 1 diabetes
DOI: https://doi.org/10.1507/endocrj.ej22-0257
[2022] Adrenal cytomegaly with elevated serum androgen levels in a patient with Beckwith-Wiedemann syndrome
DOI: https://doi.org/10.1507/endocrj.ej21-0261
[2022] Significance of simultaneous fasting plasma glucose and glycosylated hemoglobin testing in urinary glucose screening
DOI: https://doi.org/10.1111/ped.15107
[2021] Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes
DOI: https://doi.org/10.1111/jdi.13618
[2021] 607-P: Glycemic Metrics in Japanese Flash Glucose Monitoring Users by Diabetes Type and Therapy
DOI: https://doi.org/10.2337/db21-607-p
[2021] Advanced Insulin Treatment and Management in Diabetes Mellitus
DOI: https://doi.org/10.4264/numa.80.3_153
[2021] Glucagon stimulation test as a possible predictor of residual β‐cell function
DOI: https://doi.org/10.1111/ped.14462
[2021] Neonatal Sepsis-Like Syndrome with Human Parechovirus Type 4
DOI: https://doi.org/10.4264/numa.80.1_41
[2021] Nutrient management in the intrapartum period in maternal maple syrup urine disease
DOI: https://doi.org/10.1016/j.ymgmr.2021.100711
[2021] Greater insulin resistance in short children born small‐for‐gestational age than in children with growth hormone deficiency at the early period of growth hormone therapy
DOI: https://doi.org/10.1111/ped.14603
[2021] Effectiveness of a smartphone application on medication adherence in children with short stature receiving GH therapy: A multicenter prospective cohort study (GTL-App)
DOI: https://doi.org/10.1297/cpe.30.85
[2021] Residual endogenous insulin secretion in Japanese children with type 1A diabetes
DOI: https://doi.org/10.1297/cpe.30.27
[2021] A case report with functional characterization of a <i>HNF1B</i> mutation (p.Leu168Pro) causing MODY5
DOI: https://doi.org/10.1297/cpe.30.179

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。

AI 要約（直近 5 年の研究成果）

外部リンク

関連研究室(8 件)

研究成果（30 件）

科研費（0 件）

所属学会・役職（0 件）